These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15468597)

  • 21. Adenylyl cyclase gene transfer in heart failure.
    Hammond HK
    Ann N Y Acad Sci; 2006 Oct; 1080():426-36. PubMed ID: 17132799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy targeted at calcium handling as an approach to the treatment of heart failure.
    Hoshijima M
    Pharmacol Ther; 2005 Mar; 105(3):211-28. PubMed ID: 15737405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for gene therapy for heart failure.
    Hajjar RJ; del Monte F; Matsui T; Rosenzweig A
    Circ Res; 2000 Mar; 86(6):616-21. PubMed ID: 10746995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes.
    McKinsey TA; Olson EN
    J Clin Invest; 2005 Mar; 115(3):538-46. PubMed ID: 15765135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-viral and viral vectors for gene therapy.
    Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
    Feldman DS; Carnes CA; Abraham WT; Bristow MR
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
    Hajjar RJ; Zsebo K; Deckelbaum L; Thompson C; Rudy J; Yaroshinsky A; Ly H; Kawase Y; Wagner K; Borow K; Jaski B; London B; Greenberg B; Pauly DF; Patten R; Starling R; Mancini D; Jessup M
    J Card Fail; 2008 Jun; 14(5):355-67. PubMed ID: 18514926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in gene-based therapy for heart failure.
    Ly HQ; Kawase Y; Hajjar RJ
    J Cardiovasc Transl Res; 2008 Jun; 1(2):127-36. PubMed ID: 20559907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic strategies for brain tumor therapy.
    Lawler SE; Peruzzi PP; Chiocca EA
    Cancer Gene Ther; 2006 Mar; 13(3):225-33. PubMed ID: 16138122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
    Adriaansen J; Vervoordeldonk MJ; Tak PP
    Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting calcium cycling proteins in heart failure through gene transfer.
    del Monte F; Hajjar RJ
    J Physiol; 2003 Jan; 546(Pt 1):49-61. PubMed ID: 12509478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What can cardiovascular gene transfer learn from genomics: and vice versa?
    Kim TH; Skelding KA; Nabel EG; Simari RD
    Physiol Genomics; 2002 Dec; 11(3):179-82. PubMed ID: 12464691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene transfer in cardiac myocytes.
    Chaudhri BB; del Monte F; Harding SE; Hajjar RJ
    Surg Clin North Am; 2004 Feb; 84(1):141-59, ix-x. PubMed ID: 15053187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult stem cells and heart regeneration.
    Sohn RL; Jain M; Liao R
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):507-17. PubMed ID: 17489674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular biological intervention.
    Isaka Y; Imai E
    Semin Nephrol; 1996 Nov; 16(6):591-8. PubMed ID: 9125804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient, cardiac-specific adenoviral gene transfer in rat heart by isolated retrograde perfusion in vivo.
    O'Donnell JM; Lewandowski ED
    Gene Ther; 2005 Jun; 12(12):958-64. PubMed ID: 15789062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right ventricular beneficial effects of beta adrenergic receptor kinase inhibitor (betaARKct) gene transfer in a rat model of severe pressure overload.
    Molina EJ; Gupta D; Palma J; Gaughan JP; Macha M
    Biomed Pharmacother; 2009 Jun; 63(5):331-6. PubMed ID: 18801641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.